Pain for big pharma as USFDA warnings double 18% of new products to be delayed
This will impact about 180 abbreviated new drug applications, or 18 per cent of the total pipeline of large drug makers, delaying…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
USFDA inspects Alembic Pharma’s facility in Karkhadi
The US health regulator issued a form 483 with two observations
Wockhardt gets DCGI approval for two new antibiotics
EMROK (IV) and EMROK-O (Oral) have got approval for acute bacterial skin and skin structure infections including diabetic foot…
NCB busts psychotropic medicines racket seizes over 7 lakh tablets, injections
A total of 7,24,840 tablets and capsules, 1,400 injections and 80 CBCS (codeine-based cough syrup) bottles have been seized, an…
Dr Kiran Mazumdar-Shaw honoured with Australia’s highest civilian honour
The award was given for her significant service to advancing Australia's bilateral relationship with India, particularly in…
Strides arm receives EIR for its US facility
Strides Pharma Inc received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at its…
Cipla announces closure of USFDA inspection at Patalganga facility
Following the inspection by USFDA in November last year, the company has received the Establishment Inspection Report (EIR),…
Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO
Eli Lilly has been on a deal-making spree in recent years in a bid to increase products and sales in core franchises as older…
Govt may impose anti-dumping duty on pharma chemical from China, Saudi Arabia
Countries carry out anti-dumping probe to determine whether their domestic industries have been hurt because of a surge in cheap…
Piramal divests its DRG Business for $950 million
PEL had initially invested US$650 Million in 2012 to acquire DRG out of which $260 Mn was infused as equity